全文获取类型
收费全文 | 7400篇 |
免费 | 728篇 |
国内免费 | 1篇 |
出版年
2023年 | 27篇 |
2022年 | 56篇 |
2021年 | 124篇 |
2020年 | 53篇 |
2019年 | 84篇 |
2018年 | 70篇 |
2017年 | 59篇 |
2016年 | 144篇 |
2015年 | 283篇 |
2014年 | 327篇 |
2013年 | 417篇 |
2012年 | 505篇 |
2011年 | 473篇 |
2010年 | 327篇 |
2009年 | 288篇 |
2008年 | 457篇 |
2007年 | 411篇 |
2006年 | 449篇 |
2005年 | 428篇 |
2004年 | 408篇 |
2003年 | 411篇 |
2002年 | 337篇 |
2001年 | 127篇 |
2000年 | 102篇 |
1999年 | 121篇 |
1998年 | 119篇 |
1997年 | 76篇 |
1996年 | 76篇 |
1995年 | 69篇 |
1994年 | 66篇 |
1993年 | 68篇 |
1992年 | 78篇 |
1991年 | 65篇 |
1990年 | 61篇 |
1989年 | 47篇 |
1988年 | 57篇 |
1987年 | 44篇 |
1986年 | 65篇 |
1985年 | 65篇 |
1984年 | 45篇 |
1983年 | 42篇 |
1982年 | 46篇 |
1981年 | 38篇 |
1980年 | 43篇 |
1979年 | 44篇 |
1978年 | 39篇 |
1976年 | 29篇 |
1974年 | 26篇 |
1973年 | 28篇 |
1966年 | 27篇 |
排序方式: 共有8129条查询结果,搜索用时 15 毫秒
981.
982.
M Signal A Le Compte DL Harris PJ Weston JE Harding G Chase 《Biomedical engineering online》2012,11(1):45
ABSTRACT: BACKGROUND: : Abnormal blood glucose (BG) concentrations have been associated with increased morbidity and mortality in both critically ill adults and infants. Furthermore, hypoglycaemia and glycaemic variability have both been independently linked to mortality in these patients. Continuous Glucose Monitoring (CGM) devices have the potential to improve detection and diagnosis of these glycaemic abnormalities. However, sensor noise is a trade-off of the high measurement rate and must be managed effectively if CGMs are going to be used to monitor, diagnose and potentially help treat glycaemic abnormalities. AIM: To develop a tool that will aid clinicians in identifying unusual CGM behaviour and highlight CGM data that potentially need to be interpreted with care. METHOD: S: CGM data and BG measurements from 50 infants at risk of hypoglycaemia were used. Unusual CGM measurements were classified using a stochastic model based on the kernel density method and historical CGM measurements from the cohort. CGM traces were colour coded with very unusual measurements coloured red, highlighting areas to be interpreted with care. A 5-fold validation of the model was Monte Carlo simulated 25 times to ensure an adequate model fit. RESULTS: : The stochastic model was generated using ~67,000 CGM measurements, spread across the glycaemic range ~2-10mmol/L. A 5-fold validation showed a good model fit: the model 80% confidence interval (CI) captured 83% of clinical CGM data, the model 90% CI captured 91% of clinical CGM data, and the model 99% CI captured 99% of clinical CGM data. Three patient examples show the stochastic classification method in use with 1) A stable, low variability patient which shows no unusual CGM measurements, 2) A patient with a very sudden, short hypoglycaemic event (classified as unusual), and, 3) A patient with very high, potentially un-physiological, glycaemic variability after day 3 of monitoring (classified as very unusual). CONCLUSIONS: : This study has produced a stochastic model and classification method capable of highlighting unusual CGM behaviour. This method has the potential to classify important glycaemic events (e.g. hypoglycaemia) as true clinical events or sensor noise, and to help identify possible sensor degradation. Colour coded CGM traces convey the information quickly and efficiently, while remaining computationally light enough to be used retrospectively or in real-time. 相似文献
983.
Self-assembling protein nanocapsules can be engineered for various bionanotechnology applications. Using the dodecahedral scaffold of the E2 subunit from pyruvate dehydrogenase, we introduced non-native surface cysteines for site-directed functionalization. The modified nanoparticle's structural, assembly, and thermostability properties were comparable to the wild-type scaffold (E2-WT), and after conjugation of poly(ethylene glycol) (PEG) to these cysteines, the nanoparticle remained intact and stable up to 79.7 ± 1.8 °C. PEGylation of particles reduced uptake by human monocyte-derived macrophages and MDA-MB-231 breast cancer cells, with decreased uptake as PEG chain length is increased. In vitro C4-depletion and C5a-production assays yielded 97.6 ± 10.8% serum C4 remaining and 40.1 ± 6.0 ng/mL C5a for E2-WT, demonstrating that complement activation is weak for non-PEGylated E2 nanoparticles. Conjugation of PEG to these particles moderately increased complement response to give 79.7 ± 6.0% C4 remaining and 87.6 ± 10.1 ng/mL C5a. Our results demonstrate that PEGylation of the E2 protein nanocapsules can modulate cellular uptake and induce low levels of complement activation, likely via the classical/lectin pathways. 相似文献
984.
Berquam-Vrieze KE Swing DA Tessarollo L Dupuy AJ 《Genesis (New York, N.Y. : 2000)》2012,50(2):112-118
The Notch1 receptor plays a critical role in cell fate decisions during development. Activation of Notch signaling has been implicated in several types of cancer, particularly T-cell acute lymphoblastic leukemia (T-ALL). Consequently, several transgenic mouse strains have been made to study the role of Notch1 in T-ALL. However, the existing Notch1 transgenic lines mimic a translocation event found in only ~1% of T-ALL cases. Here we describe three novel NOTCH1 transgenic mouse strains that have Cre-inducible expression of the entire human NOTCH1 locus, each possessing a common mutation found in T-ALL. Unlike existing Notch1 transgenic strains, these NOTCH1 transgenic strains express full-length receptors from an endogenous human promoter that should be susceptible to a number of Notch antagonists that have recently been developed. These strains will allow researchers to modulate Notch signaling to study both normal development and cancer biology. 相似文献
985.
Sabat R Chanwangpong A Schneider-Burrus S Metternich D Kokolakis G Kurek A Philipp S Uribe D Wolk K Sterry W 《PloS one》2012,7(2):e31810
Background
Acne inversa (AI; also designated as Hidradenitis suppurativa) is a common chronic inflammatory skin disease, localized in the axillary, inguinal and perianal skin areas that causes painful, fistulating sinuses with malodorous purulence and scars. Several chronic inflammatory diseases are associated with the metabolic syndrome and its consequences including arteriosclerosis, coronary heart disease, myocardial infraction, and stroke. So far, the association of AI with systemic metabolic alterations is largely unexplored.Methods and Findings
A hospital-based case-control study in 80 AI patients and 100 age- and sex-matched control participants was carried out. The prevalence of central obesity (odds ratio 5.88), hypertriglyceridemia (odds ratio 2.24), hypo-HDL-cholesterolemia (odds ratio 4.56), and hyperglycemia (odds ratio 4.09) in AI patients was significantly higher than in controls. Furthermore, the metabolic syndrome, previously defined as the presence of at least three of the five alterations listed above, was more common in those patients compared to controls (40.0% versus 13.0%; odds ratio 4.46, 95% confidence interval 2.02 to 9.96; P<0.001). AI patients with metabolic syndrome also had more pronounced metabolic alterations than controls with metabolic syndrome. Interestingly, there was no correlation between the severity or duration of the disease and the levels of respective parameters or the number of criteria defining the metabolic syndrome. Rather, the metabolic syndrome was observed in a disproportionately high percentage of young AI patients.Conclusions
This study shows for the first time that AI patients have a high prevalence of the metabolic syndrome and all of its criteria. It further suggests that the inflammation present in AI patients does not have a major impact on the development of metabolic alterations. Instead, evidence is given for a role of metabolic alterations in the development of AI. We recommend monitoring of AI patients in order to correct their modifiable cardiovascular risk factors. 相似文献986.
Tularemia, caused by the gram-negative bacterium Francisella tularensis, is a severe, sometimes fatal disease. Interest in tularemia has increased over the last decade due to its history as a biological weapon. In particular, development of novel vaccines directed at protecting against pneumonic tularemia has been an important goal. Previous work has demonstrated that, when delivered at very high inoculums, administration of live, highly attenuated strains of virulent F. tularensis can protect against tularemia. However, lower vaccinating inoculums did not offer similar immunity. One concern of using live vaccines is that the host may develop mild tularemia in response to infection and use of high inoculums may contribute to this issue. Thus, generation of a live vaccine that can efficiently protect against tularemia when delivered in low numbers, e.g. <100 organisms, may address this concern. Herein we describe the ability of three defined, attenuated mutants of F. tularensis SchuS4, deleted for FTT0369c, FTT1676, or FTT0369c and FTT1676, respectively, to engender protective immunity against tularemia when delivered at concentrations of approximately 50 or fewer bacteria. Attenuated strains for use as vaccines were selected by their inability to efficiently replicate in macrophages in vitro and impaired replication and dissemination in vivo. Although all strains were defective for replication in vitro within macrophages, protective efficacy of each attenuated mutant was correlated with their ability to modestly replicate and disseminate in the host. Finally, we demonstrate the parenteral vaccination with these strains offered superior protection against pneumonic tularemia than intranasal vaccination. Together our data provides proof of principle that low dose attenuated vaccines may be a viable goal in development of novel vaccines directed against tularemia. 相似文献
987.
Costa VV Fagundes CT Valadão DF Cisalpino D Dias AC Silveira KD Kangussu LM Ávila TV Bonfim MR Bonaventura D Silva TA Sousa LP Rachid MA Vieira LQ Menezes GB de Paula AM Atrasheuskaya A Ignatyev G Teixeira MM Souza DG 《PLoS neglected tropical diseases》2012,6(5):e1663
There are few animal models of dengue infection, especially in immunocompetent mice. Here, we describe alterations found in adult immunocompetent mice inoculated with an adapted Dengue virus (DENV-3) strain. Infection of mice with the adapted DENV-3 caused inoculum-dependent lethality that was preceded by several hematological and biochemical changes and increased virus dissemination, features consistent with severe disease manifestation in humans. IFN-γ expression increased after DENV-3 infection of WT mice and this was preceded by increase in expression of IL-12 and IL-18. In DENV-3-inoculated IFN-γ(-/-) mice, there was enhanced lethality, which was preceded by severe disease manifestation and virus replication. Lack of IFN-γ production was associated with diminished NO-synthase 2 (NOS2) expression and higher susceptibility of NOS2(-/-) mice to DENV-3 infection. Therefore, mechanisms of protection to DENV-3 infection rely on IFN-γ-NOS2-NO-dependent control of viral replication and of disease severity, a pathway showed to be relevant for resistance to DENV infection in other experimental and clinical settings. Thus, the model of DENV-3 infection in immunocompetent mice described here represents a significant advance in animal models of severe dengue disease and may provide an important tool to the elucidation of immunopathogenesis of disease and of protective mechanisms associated with infection. 相似文献
988.
Vivian V. Costa Caio T. Fagundes Deborah F. Valad?o Daniel Cisalpino Ana Carolina F. Dias K��tia D. Silveira Lucas M. Kangussu Thiago V. ��vila Maria Rosa Q. Bonfim Daniela Bonaventura Tarc��lia A. Silva Lirlandia P. Sousa Milene A. Rachid Leda Q. Vieira Gustavo B. Menezes Ana Maria de Paula Alena Atrasheuskaya George Ignatyev Mauro M. Teixeira Danielle G. Souza 《PLoS neglected tropical diseases》2012,6(5)
989.
990.
O'Brien DP McDonald A Callan P Robson M Friedman ND Hughes A Holten I Walton A Athan E 《PLoS neglected tropical diseases》2012,6(1):e1473